Exploring the Tumor Microenvironment in Cancer Treatment
May 19, 2021PTV-05-21-CL-003
Ronald Herbst, CSO of Pyxis Oncology discusses the potential of immunotherapy, understanding T cells in the tumor microenvironment, and ADCs in the company's pipeline.
